Pregnancy Induced Hypertension (PIH) Completed Phase 2 Trials for Labetalol (DB00598)

Also known as: Hypertension, Pregnancy Induced / Pregnancy Induced Hypertension / Pregnancy associated hypertension / Gestational [pregnancy-induced] hypertension without significant proteinuria / Gestational hypertension / Hypertension, Pregnancy-Induced / PIH Pregnancy induced hypertension

IndicationStatusPhase
DBCOND0125910 (Pregnancy Induced Hypertension (PIH))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02050529Randomized Controlled Trial of Labetalol Versus Hydralazine for Severe Hypertension in Obstetric Patients.Treatment